Acute coronary syndrome and severe haemophilia: An unusual association with challenging treatment

Thrombosis and Haemostasis

Volumn 103, Issue 6, 2010, Pages 1270-1272

  Coppola, Antonio ^a   De Simone, Ciro ^a   Di Capua, Mirko ^a   Tufano, Antonella ^a   Cimino, Ernesto ^a   Conca, Paolo ^a   Guida, Anna ^a   Morisco, Carmine ^a   Di Minno, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; AMLODIPINE; ATENOLOL; CLOPIDOGREL; DIURETIC AGENT; DOXAZOSIN; FONDAPARINUX; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; NITRIC ACID DERIVATIVE; RAMIPRIL; RECOMBINANT BLOOD CLOTTING FACTOR 8; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 8; COAGULATING AGENT; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; BLEEDING; CASE REPORT; COMORBIDITY; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DRUG CHOICE; HEMOPHILIA; HUMAN; HYPERTENSION; LETTER; LOW DRUG DOSE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TREATMENT PLANNING; ANALOGS AND DERIVATIVES; DYSPNEA; FATALITY; HEART INFARCTION; HEMOPHILIA A; KIDNEY FAILURE; MIDDLE AGED; PATHOPHYSIOLOGY; PRACTICE GUIDELINE;

ACUTE CORONARY SYNDROME; ANTICOAGULANTS; COAGULANTS; COMORBIDITY; CORONARY ANGIOGRAPHY; DYSPNEA; FACTOR VIII; FATAL OUTCOME; HEMOPHILIA A; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; RENAL INSUFFICIENCY; TICLOPIDINE;

EID: 77953151904     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-11-0766     Document Type: Letter

References (21)

1. Tuinenburg A, Mauser-Bunschoten EP, Verhaar MC, et al. Cardiovascular disease in patients with hemophilia. J Thromb Haemost 2009; 7: 247-254.
2. Franchini M, Tagliaferri A, Mannucci PM. The management of hemophilia in elderly patients. Clin Interv Aging 2007; 2: 361-368.
3. Mauser-Bunschoten EP, van de Putte DEF, Schutgens REG. Co-morbidity in the ageing haemophilia patient: the down side of increased life expectancy. Haemophilia 2009; 15: 853-863.
4. Mannucci PM, Schutgens REG, Santagostino E, et al. How I treat age-related morbidities in elderly persons with hemophilia. Blood 2009; 114: 5256-5263.
5. Girolami A, Ruzzon E, Fabris F, et al. Myocardial infarction and other arterial occlusions in hemophilia A patients. Acta Haematol 2006; 116: 120-125.
6. Siboni SM, Mannucci PM, Gringeri A, et al. Health status and quality of life of elderly patients with severe hemophilia born before the advent of modern replacement therapy. J Thromb Hemost 2009; 7: 780-786.
7. Miesbach W, Alesci S, Krekeler S, et al. Comorbidities and bleeding pattern in elderly haemophilia patients. Haemophilia 2009; 15: 894-899.
8. Schutgens REG, Tuinenburg A, Roosendal G, et al. Treatment of ischemic heart disease in haemophilia patients: an istitutional guideline. Haemophilia 2009; 15: 952-958.
9. Peerlink K, Vermylen J. Acute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitor. Thromb Haemost 1999; 82: 1775-1776.
10. Au WY, Jim MH, Lam CC. Unusual case of coronary artery disease in a patient with severe hemophilia B. Am J Hematol 2002; 69: 152-153.
11. Bovenzi F, De Luca L, Signore N, et al. Abciximab for the treatment of an acute thrombotic coronary occlusion during stent implantation in a patient with severe hemophilia B. Ital Heart J 2003; 4: 728-730.
12. Arora UK, Dhir M, Cintron G, et al. Successful multi-vessel percutaneous coronary intervention with bivalirudin in a patient with severe hemophilia A: a case report and review of literature. J Invasive Cardiol 2004; 16: 330-332. (Pubitemid 38715817)
13. Krolick MA. Successful percutaneous coronary intervention in a patient with severe haemophilia A using bivalirudin as the sole procedural anticoagulant. Haemophilia 2005; 11: 415-417.
14. Ferrario C, Renders F, Cairoli A, et al. Management of an acute coronary syndrome in a patient with severe haemophilia A. Haemophilia 2007; 13: 763-765.
15. Rivolta GF, Di Perna C, Franchini M, et al. Management of coronary artery disease in a severe haemophilia patient with high titre inhibitor and anaphylaxis. Haemophilia 2009; 15: 1161-1163.
16. De Luca G, Cassetti E, Verdoia M, et al. Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: a meta-analyis of randomised trials. Thromb Haemost 2009; 102: 428-436.
17. Quintero D, Biria M, Meyers DG. Percutaneous coronary intervention in a patient with acute ST-elevation myocardial infarction and hemophilia A. J Invasive Cardiol 2008; 20: 240-241. (Pubitemid 351643273)
18. Kerkhoffs JL, Atsma DE, Oemrawsingh PV, et al. Acute myocardial infarction during substitution with recombinant factor VIII concentrate in a patient with mild hemophilia A. Thromb Haemost 2004; 92: 425-426.
19. Virtanen R, Kauppila M, Itälä M. Percutaneous coronary intervention with stenting in a patient with hemophilia A and an acute myocardial infarction following a single dose of desmopressin. Thromb Haemost 2004; 92: 1154-1156. (Pubitemid 39545543)
20. Smolka G, Kulach A, Dabek J, et al. Percutaneous coronary intervention with stent implantation in haemophilic A patient with unstable angina. Haemophilia 2007; 13: 428-431.
21. May AE, Geisler T, Gawaz M. Individualized anti-thrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding. Thromb Haemost 2008; 99: 487-493.